Literature DB >> 28855399

Subcutaneous drug delivery: An evolving enterprise.

Graham B Jones1, David S Collins2, Michael W Harrison2, Nagarajan R Thyagarajapuram2, Justin M Wright2.   

Abstract

Recent advances in subcutaneous drug delivery and device design are transforming the biopharmaceutical sector and improving patient care.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh：

Year:  2017        PMID： 28855399     DOI： 10.1126/scitranslmed.aaf9166

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  6 in total

Review 1.  Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction.

Authors:  Wei Chen; Bryant C Yung; Zhiyong Qian; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

2.  Novel cannula design improves large volume auto-injection rates for high viscosity solutions.

Authors:  Bruce C Roberts; Christopher Rini; Rick Klug; Douglas B Sherman; Didier Morel; Ronald J Pettis
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

3.  Formative Study on the Wearability and Usability of a Large-Volume Patch Injector.

Authors:  Jakob Lange; Andreas Schneider; Christoph Jordi; Michael Lau; Timothy Disher
Journal:  Med Devices (Auckl)       Date:  2021-11-16

4.  Envisioning Post-pandemic Digital Neurological, Psychiatric and Mental Health Care.

Authors:  Amit Khanna; Graham B Jones
Journal:  Front Digit Health       Date:  2021-12-21

5.  Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects.

Authors:  Wendy D Woodley; Wen Yue; Didier R Morel; Audrey Lainesse; Ronald J Pettis; Natasha G Bolick
Journal:  Clin Transl Sci       Date:  2021-03-25       Impact factor: 4.689

Review 6.  Self-assembled mRNA vaccines.

Authors:  Jeonghwan Kim; Yulia Eygeris; Mohit Gupta; Gaurav Sahay
Journal:  Adv Drug Deliv Rev       Date:  2021-01-02       Impact factor: 17.873
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.